People channel feed

It's Mon­cef Slaoui. Trump ad­min­is­tra­tion set­tles on ex-GSK vac­cines chief as Covid-19 R&D czar — re­ports

5 years ago
Coronavirus

The new CEO at trou­bled AM­AG be­gins his bat­tle against an ar­ray of threats by ax­ing staff and slash­ing costs

5 years ago
R&D
FDA+

Vivek Ra­maswamy’s broth­er, Shankar, spins out on his own, launch­ing au­da­cious gene ther­a­py play

6 years ago
Financing
Startups

Ex-DARPA chief Regi­na Dugan, for­mer Il­lu­mi­na CEO Jay Flat­ley lead $300M Well­come Trust fund to tack­le glob­al health's Sput­nik mo­ment

6 years ago

Top Genen­tech re­searcher steps away and Roche turns to the Broad for a star re­place­ment play­er

6 years ago
R&D

J&J R&D ex­ec Na­jat Khan — and da­ta sci­ence — are get­ting an el­e­vat­ed role at the phar­ma gi­ant

6 years ago
R&D
AI

Ab­b­Vie gets the FTC's di­vid­ed bless­ing for its $63B Al­ler­gan buy­out — free­ing Brent Saun­ders to blaze a new path

6 years ago
Deals

Oust­ed BAR­DA chief Rick Bright blasts HHS of­fi­cial for a long record of im­prop­er in­ter­fer­ence that pre­ced­ed the pan­dem­ic

6 years ago
R&D

Kel­ly Mar­tin skips to a new CEO suite as his last biotech team rais­es the white flag

6 years ago

Sue Desmond-Hell­mann joins the mar­quee crowd of bio­phar­ma ex­perts at GV boot­ing up a new gen­er­a­tion of drug hunters

6 years ago

Eli Lil­ly ex­ecs have been think­ing about the longterm ef­fects of the pan­dem­ic and dam­age con­trol. Here’s what they be­lieve

6 years ago
R&D
Coronavirus

Bio­gen’s top ex­ec­u­tive crew has a big cred­i­bil­i­ty is­sue. And they seem de­ter­mined to make it worse

6 years ago
Bioregnum
Opinion

De­posed BAR­DA chief blasts Trump ad­min­is­tra­tion on pro­mot­ing un­proven drugs as Covid-19 panacea: 'Science — not pol­i­tics or crony­ism — has to lead the way'

6 years ago
Coronavirus

A long­time Lau­ra Shawver fan calls the se­r­i­al en­tre­pre­neur back to the helm of a biotech up­start

6 years ago
Startups

BAR­DA chief leaves po­si­tion as agency en­ters un­prece­dent­ed vac­cine cam­paign, rais­ing ques­tions about fed­er­al Covid-19 re­sponse

6 years ago
Coronavirus

Still no ad­u­canum­ab fil­ing and an in-house gath­er­ing trig­gered a health dis­as­ter, but Bio­gen's CEO nev­er­the­less took home record pay

6 years ago

It’s not the mon­ey: The lat­est For­tune list of the top 10 bio­phar­mas to work for in­cludes a few sur­prise play­ers

6 years ago

Pas­cal So­ri­ot, lamenter of low pay, faces in­vestor re­volt for be­ing over­com­pen­sat­ed

6 years ago

Phar­ma­cyclics bil­lion­aire Bob Dug­gan takes the helm of an­oth­er biotech — and he faces an even big­ger up­hill climb this time

6 years ago

Q&A: An­a­lyst-turned biotech ex­ec-turned an­a­lyst reads the biotech Q1 tea leaves

6 years ago
R&D
Pharma

Bio­phar­ma bil­lion­aires dom­i­nate Forbes' list of the world's top 10 wealth­i­est health­care ex­ecs — and the pan­dem­ic has­n't hurt

6 years ago

Ready to de­clare a de­fin­i­tive come­back in two months, Im­munomedics stops PhI­II ear­ly, re­cruits new CEO

6 years ago
R&D

The 20 un­der 40: In­side the next gen­er­a­tion of bio­phar­ma lead­ers

6 years ago
Special

Mo­tion de­nied: Gilead still on the hook for $1.5B in dam­ages over CAR-T patent dis­pute with Bris­tol My­ers Squibb

6 years ago
Cell/Gene Tx
First page Previous page 68697071727374 Next page Last page
A service from the Financial Times